90Y-hMN14

90Y-hMN14 · Gilead Sciences

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for 90Y-hMN14, covering 2021-08-19 to 2021-08-19. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of 90Y-hMN14 to Treat Pancreatic Cancer [Phase 1, Phase 2]